FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/10/2026
Leerink Partners raised its price target on Aclaris Therapeutis (NASDAQ: ACRS) to $56.00 (from $54.00) while maintaining a Outperform rating.